Mongolia vs Syria: Cause of death, by non-communicable diseases, ages 5-14
Mongolia
31.1%
in 2021
Syria
30.4%
in 2021
Mongolia rank
114th
Syria rank
116th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Mongolia
- Syria
How they compare
Mongolia currently reports 31.1% against 30.4% in Syria, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Syria ahead.
Mongolia ranks 114th and Syria ranks 116th of 185 countries.
Across the 3 decades both report, Mongolia averaged higher in 2 and Syria in 1.
Head to head by decade
| Decade | Mongolia | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.8% | 47.0% | 20.2% | Syria |
| 2010s | 28.6% | 23.4% | 5.2% | Mongolia |
| 2020s | 30.7% | 29.2% | 1.5% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Mongolia or Syria?
- Mongolia, at 31.1% against 30.4% in Syria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Mongolia and Syria?
- 0.7%, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and Syria?
- 6 years are reported by both, from 2000 to 2021.
- How do Mongolia and Syria rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Mongolia ranks 114th and Syria ranks 116th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.